The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in Serum
Open accessAbstract
Purpose: Cell-free DNA circulating in serum is a candidate molecular biomarker for malignant tumors. Unlike uniformly truncated DNA released from apoptotic cells, DNA released from dead cancer cells varies in size. Serum DNA integrity, the ratio of longer fragments to total DNA, may be clinically useful for detecting breast cancer progression. Patients and Methods: Serum samples from 51 healthy females and 83 females with primary breast cancers (eight American Joint Committee on Cancer stage 0, 24 stage I, 27 stage II, 21 stage III, and three stage IV) were assessed preoperatively. Serum DNA integrity was assessed by fragment length-dependent quantitative real-time polymerase chain reaction of ALU DNA repeats. Results: Mean serum DNA integrity was significantly higher in patients with stage II, III, and IV breast cancers than in healthy females (P = .005, P < .0001, and P = .002, respectively). The receiver operating characteristic (ROC) curve for discriminating patients with stage II or more advanced breast cancers from healthy females had an area under the curve (AUC) of 0.79 (95% CI, 0.70 to 0.86). Mean serum DNA integrity was positively correlated to size of invasive cancers (r = 0.48; P < .0001) and significantly higher in the presence of lymphovascular invasion (LVI; 0.25 ± 0.02 v 0.17 ± 0.02; P < .0001) or lymph node (LN) metastasis (0.27 ± 0.02 v 0.14 ± 0.02; P < .0001). The ROC curve for discriminating LN metastasis had an AUC of 0.81 (95% CI, 0.72 to 0.89). Serum DNA integrity and LVI were significant for predicting LN metastasis in a multivariate analysis (P = .0002 and P < .0001, respectively). Conclusion: Integrity of serum circulating DNA is a promising molecular biomarker for detecting breast cancer tumor progression and regional LN metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Wyllie, A. H. (1980) · Nature · doi:10.1038/284555a0 · Cited by 4,504
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,169
(1977) · PubMed · Cited by 1,801
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326
Fisher, B., Bauer, M., Wickerham, D. L., Redmond, C. K., Fisher, E. R., Cruz, A. B., Foster, R., Gardner, B., Lerner, H., Margolese, R., et al. (1983) · Cancer · doi:10.1002/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3 · Cited by 1,034
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.
Sánchez‐Céspedes, M., Esteller, M., Wu, L. J., Nawroz-Danish, H., Yoo, G., Koch, W. M., Jen, J., Herman, J. G., & Sidransky, D. (2000) · PubMed · Cited by 540
Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients
Anker, P., Mulcahy, H., Qi Chen, X., & Stroun, M. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006260319913 · Cited by 451
Giacona, M. B., Ruben, G. C., Iczkowski, K. A., Roos, T. B., Porter, D. M., & Sorenson, G. D. (1998) · Pancreas · doi:10.1097/00006676-199807000-00012 · Cited by 387
Umetani, N., Kim, J., Hiramatsu, S., Reber, H. A., Hines, O. J., Bilchik, A. J., & Hoon, D. S. B. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068577 · Cited by 331
Self-citationIncreased plasma DNA integrity in cancer patients.
Wang, B. G., Huang, H. Y., Chen, Y., Bristow, R. E., Kassauei, K., Cheng, C., Roden, R. B. S., Sokoll, L. J., Chan, D. W., & Shih, I. (2003) · PubMed · Cited by 326
DNA methylation in serum of breast cancer patients: an independent prognostic marker.
Müller, H. M., Widschwendter, A., Fiegl, H., Ivarsson, L., Goebel, G., Perkmann, E., Marth, C., & Widschwendter, M. (2003) · PubMed · Cited by 317
Fiegl, H., Millinger, S., Mueller-Holzner, E., Marth, C., Ensinger, C., Berger, A., Klocker, H., Goebel, G., & Widschwendter, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2438 · Cited by 252
Changes in Concentration of DNA in Serum and Plasma during Storage of Blood Samples
Jung, M., Klotzek, S., Lewandowski, M., Fleischhacker, M., & Jung, K. (2003) · Clinical Chemistry · doi:10.1373/49.6.1028 · Cited by 233
Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients
Dulaimi, E., Hillinck, J., de Caceres, I. I., Al-Saleem, T., & Cairns, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0597 · Cited by 232
Insertion and/or deletion of many repeated DNA sequences in human and higher ape evolution.
Hwu, H. R., Roberts, J. W., Davidson, E. H., & Britten, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3875 · Cited by 180
Mori, T., O’Day, S. J., Umetani, N., Martinez, S. R., Kitago, M., Koyanagi, K., Kuo, C., Takeshima, T.-L., Milford, R., Wang, H.-J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9876 · Cited by 167
Self-citationSilva, J. M., Silva, J., Sánchez, A., Garcia, J. M., Domínguez, G., Provencio, M., Sanfrutos, L., Jareño, E., Colas, A., España, P., et al. (2002) · PubMed · Cited by 142
Holdenrieder, S., Stieber, P., von Pawel, J., Raith, H., Nagel, D., Feldmann, K., & Seidel, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0625 · Cited by 140
Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR
Gal, S., Fidler, C., Lo, Y. M. D., Taylor, M., Han, C., Moore, J., Harris, A. L., & Wainscoat, J. S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601609 · Cited by 125
Challenges for Biomarkers in Cancer Detection
Wagner, P. D., Verma, M., & Srivastava, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.003 · Cited by 123
Umetani, N., Hiramatsu, S. H., & Hoon, D. S. �. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.040 · Cited by 113
Self-citationQuantitative Analysis of Circulating Plasma DNA as a Tumor Marker in Thoracic Malignancies
Herrera, L. J., Raja, S., Gooding, W. E., El‐Hefnawy, T., Kelly, L. A., Luketich, J. D., & Godfrey, T. E. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.039263 · Cited by 111
Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients
Taback, B., O'Day, S. J., & Hoon, D. S. �. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.004 · Cited by 91
Self-citationGu, Z., Wang, H., Nekrutenko, A., & Li, W. (2000) · Gene · doi:10.1016/s0378-1119(00)00434-0 · Cited by 82
Circulating Nucleic Acids and Proteomics of Plasma/Serum: Clinical Utility
Taback, B., & Hoon, D. S. �. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.002 · Cited by 64
Self-citationAllelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome
Fujimoto, A., O'Day, S. J., Taback, B., Elashoff, D. A., & Hoon, D. S. �. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0957 · Cited by 53
Self-citation
Cited by
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Self-citationGenome-wide cell-free DNA fragmentation in patients with cancer
Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D. C., Jensen, S. Ø., Medina, J. E., Hruban, C., White, J. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1272-6 · Cited by 1,476
Enhanced detection of circulating tumor DNA by fragment size analysis
Mouliere, F., Chandrananda, D., Piskorz, A. M., Moore, E. K., Morris, J., Ahlborn, L. B., Mair, R., Goranova, T., Marass, F., Heider, K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4921 · Cited by 1,069
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Jiang, P., Chan, C. W. M., Chan, K. C. A., Cheng, S. H., Wong, J., Wong, V. W.-S., Wong, G. L. H., Chan, S. L., Mok, T. S. K., Chan, H. L. Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500076112 · Cited by 738
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Lo, Y. M. D., Han, D. S. C., Jiang, P., & Chiu, R. W. K. (2021) · Science · doi:10.1126/science.aaw3616 · Cited by 662
Metadata
- Authors
- Umetani, N., Giuliano, A. E., Hiramatsu, S. H., Amersi, F., Nakagawa, T., Martino, S., & Hoon, D. S. B.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-09-10
- Volume
- 24
- Issue
- 26
- Pages
- 4270-4276
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2100675674
- Cited by
- 351
- References
- 28
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.